We are live on ! Find out more
RPRX

Repros Therapeutics Inc.
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

Back to rankings

75 hedge funds and large institutions have $199M invested in Repros Therapeutics Inc. in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $6.02M

50% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 77 → 75 (-2)

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

48% less capital invested

Capital invested by funds: $379M → $199M (-$180M)

Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
27
Reduced
18
Closed
19
Calls
$10.8M
Puts
$6.02M
Net Calls
+$4.78M
Net Calls Change
+$6.34M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$21.7M
2
PC
Paulson & Co
New York
+$14.8M
3
Millennium Management
Millennium Management
New York
+$12.2M
4
BIM
Bogle Investment Management
Massachusetts
+$11.5M
5
SAM
Senzar Asset Management
New York
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$45.2M
2
VAM
Visium Asset Management
New York
-$21.5M
3
RCM
RA Capital Management
Massachusetts
-$21.1M
4
PHS
PFM Health Sciences
California
-$14.7M
5
JHIU
Janus Henderson Investors US
Colorado
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$1.19M +$20.9K +1,413 +1%
Citadel Advisors
27
Citadel Advisors
Florida
$1.13M +$1.59M +107,578 +1,612%
PP
28
PDT Partners
New York
$991K +$1.09M +73,916 +282%
TCIM
29
TIAA CREF Investment Management
New York
$971K -$25.8K -1,744 -2%
BIM
30
BlackRock Investment Management
Delaware
$675K +$9.4K +635 +0.9%
Allianz Asset Management
31
Allianz Asset Management
Germany
$633K +$119K +8,008 +14%
HCM
32
Highbridge Capital Management
New York
$619K +$925K +62,498 New
Nomura Holdings
33
Nomura Holdings
Japan
$576K -$150K -10,131 -15%
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$535K – – –
Goldman Sachs
35
Goldman Sachs
New York
$468K -$66.6K -4,495 -9%
ST
36
Spot Trading
Illinois
$441K +$660K +44,565 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$422K +$8.03K +542 +1%
TA
38
Teachers Advisors
New York
$371K +$79.9K +5,394 +17%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$365K -$804K -54,272 -60%
NCCM
40
Nine Chapters Capital Management
New Jersey
$358K +$536K +36,200 New
MOACM
41
Mutual of America Capital Management
New York
$344K – – –
AllianceBernstein
42
AllianceBernstein
Tennessee
$338K -$26.7K -1,800 -5%
Charles Schwab
43
Charles Schwab
California
$324K – – –
TMC
44
Trellus Management Company
Florida
$307K -$281K -19,000 -38%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$297K +$444K +30,008 New
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$262K – – –
Swiss National Bank
47
Swiss National Bank
Switzerland
$261K – – –
JGC
48
J. Goldman & Co
New York
$248K +$370K +25,000 New
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$196K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$188K -$7.11K -480 -2%
1
2
3 4

RPRX Hedge Fund Activity: Q3 2014 in Review

75 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q3 2014, worth a combined $199M — down 48% from $379M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of RPRX and 17 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 27 added.

The largest buyer was Fidelity Investments, adding an estimated $21.7M. The largest seller was Franklin Resources, exiting entirely with an estimated $45.2M sold.

  • 75 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q3 2014, down from 77 in Q2 2014.
  • Funds reported $199M of Repros Therapeutics Inc. stock for Q3 2014, down 48% quarter-over-quarter.
  • 17 funds opened new Repros Therapeutics Inc. positions in Q3 2014 and 19 closed out, a net change of -2 holders.
  • The largest Repros Therapeutics Inc. buyer in Q3 2014 was Fidelity Investments, an estimated $21.7M added.
  • The largest Repros Therapeutics Inc. seller in Q3 2014 was Franklin Resources, an estimated $45.2M sold.

Based on aggregated 13F filings for Q3 2014.